Virpax PharmaceuticalsVRPX
13F holders, Q2 2025 (June 30)1holders −6
0new positions
7sold out
$0.22avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Virpax Pharmaceuticals Inc. (VRPX) in their 13F filings, down 6 from Q1 2025. 0 opened new positions and 7 sold out. The largest holder was Osaic Holdings, Inc. ($2).
- Company
- Virpax Pharmaceuticals Inc.
- CUSIP
- 928251305
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 7 | $35K |
All 13F filers, Q1 2025 → Q2 2025: 29,089 shares sold, net −29,089 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Osaic Holdings, Inc. | 0.00% | No change | 9 | $2 |
"% of holder's portfolio" is VRPX's weight in each manager's 13F, not the share of Virpax Pharmaceuticals Inc. the manager owns.